SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-117564
Filing Date
2022-04-25
Accepted
2022-04-25 16:12:55
Documents
10
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d264585ddef14a.htm DEF 14A 573530
2 GRAPHIC g264585dsp32c.jpg GRAPHIC 911
3 GRAPHIC g264585dsp62a.jpg GRAPHIC 1756
4 GRAPHIC g264585dsp62b.jpg GRAPHIC 1079
5 GRAPHIC g264585dsp62d.jpg GRAPHIC 1182
6 GRAPHIC g264585dsp62e.jpg GRAPHIC 1186
7 GRAPHIC g264585dsp62f.jpg GRAPHIC 1414
8 GRAPHIC g264585dsp63.jpg GRAPHIC 1047
9 GRAPHIC g264585dsp63a.jpg GRAPHIC 974
10 GRAPHIC g264585g01a03.jpg GRAPHIC 67487
  Complete submission text file 0001193125-22-117564.txt   681973
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39787 | Film No.: 22849806
SIC: 2836 Biological Products, (No Diagnostic Substances)